Skip to main content
NCBI home page
Gut logoLink to Gut
. 1984 Jul;25(7):784–791. doi: 10.1136/gut.25.7.784

Glucagonoma syndrome demonstrating giant duodenal villi.

F M Stevens, R W Flanagan, D O'Gorman, K D Buchanan
PMCID: PMC1432604  PMID: 6329923

Abstract

A 39 year old man developed an itchy bullous rash in the perineum and on the extremities. Six years later, after giant intestinal villi had been noted at endoscopy, a diagnosis of the glucagonoma syndrome was made. Investigation revealed a large tumour of the pancreatic body and tail. The molecular species of glucagon secreted by the tumour were characterised using the combined purification procedures of immunoaffinity chromatography followed by gel filtration.

Full text

PDF
784

Images in this article

785Fig 1
on p.785
785Fig 2
on p.785

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom S. R. An enteroglucagon tumour. Gut. 1972 Jul;13(7):520–523. doi: 10.1136/gut.13.7.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buchanan K. D., Teale J. D., Harper G. Antibodies to unconjugated synthetic and natural secretins. Horm Metab Res. 1972 Nov;4(6):507–507. doi: 10.1055/s-0028-1097109. [DOI] [PubMed] [Google Scholar]
  3. Gleeson M. H., Bloom S. R., Polak J. M., Henry K., Dowling R. H. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut. 1971 Oct;12(10):773–782. doi: 10.1136/gut.12.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holohan K. N., Murphy R. F., Flanagan R. W., Buchanan K. D., Elmore D. T. Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta. 1973 Sep 21;322(1):178–180. doi: 10.1016/0005-2795(73)90190-6. [DOI] [PubMed] [Google Scholar]
  5. Hughes C. A., Bates T., Dowling R. H. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog. Gastroenterology. 1978 Jul;75(1):34–41. [PubMed] [Google Scholar]
  6. Johnson L. R., Aures D., Yuen L. Pentagastrin-induced stimulation of protein synthesis in the gastrointestinal tract. Am J Physiol. 1969 Jul;217(1):251–254. doi: 10.1152/ajplegacy.1969.217.1.251. [DOI] [PubMed] [Google Scholar]
  7. Lightman S. L., Bloom S. R. Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma. Br Med J. 1974 Mar 2;1(5904):367–368. doi: 10.1136/bmj.1.5904.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mallinson C. N., Bloom S. R., Warin A. P., Salmon P. R., Cox B. A glucagonoma syndrome. Lancet. 1974 Jul 6;2(7871):1–5. doi: 10.1016/s0140-6736(74)91343-9. [DOI] [PubMed] [Google Scholar]
  9. Mason J. C., Murphy R. F., Henry R. W., Buchanan K. D. Starvation-induced changes in secretin-like immunoreactivity of human plasma. Biochim Biophys Acta. 1979 Jan 18;582(2):322–331. doi: 10.1016/0304-4165(79)90394-5. [DOI] [PubMed] [Google Scholar]
  10. Murphy R. F., Conlon J. M., Imam A., Kelly G. J. Comparison of non-biospecific effects in immunoaffinity chromatography using cyanogen bromide and bifunctional oxirane as immobilising agents. J Chromatogr. 1977 May 21;135(2):427–433. doi: 10.1016/s0021-9673(00)88384-3. [DOI] [PubMed] [Google Scholar]
  11. Perera D. R., Weinstein W. M., Rubin C. E. Symposium on pathology of the gastrointestinal tract-Part II. Small intestinal biopsy. Hum Pathol. 1975 Mar;6(2):157–217. doi: 10.1016/s0046-8177(75)80176-6. [DOI] [PubMed] [Google Scholar]
  12. Soler N. G., Oates G. D., Malins J. M. Glucagonoma syndrome in a young man. Proc R Soc Med. 1976 Jun;69(6):429–431. doi: 10.1177/003591577606900615. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES